Indian Air Force Anti-Blood Grouping Reagent Tender 2026 – MDR 2017 Compliance, IS0 9001, Blood Grouping Sera 2400 Estimated Value

Tender Overview

The Indian Air Force, Department of Military Affairs, invites bids for Anti-Blood Grouping Sera/Reagent for Anti-AB and Anti-D grouping. The procurement scope includes reagents with unspecified exact quantities, but an estimated value of ₹2400 is noted. Compliance with the Medical Device Rules 2017 and a valid medical device license under the Drugs and Cosmetics Act are mandatory. Bidders must demonstrate ISO 9001 certification, BIS/type test certificates, and ADP/GDIC-aligned documentation. Shelf life must meet minimum requirements on delivery. The tender emphasizes pre/post inspection, lab testing, and adherence to cold chain standards as applicable.

Key differentiators include mandatory certifications, statutory licensing, and supplier responsibility for recall and stock replacement. Unique terms cover two-year shelf life minimum under regulatory guidance and post-acceptance testing at designated labs, with external lab costs borne by the seller if AHSP facilities are unavailable.

Technical Specifications & Requirements

• Product category: Blood grouping sera/reagent; Type: Antibody reagents; Pack size: Not specified; Shelf life: Minimum required at delivery; Standards: MDR 2017; Licensing: Valid medical device license under Drugs and Cosmetics Act; Quality: ISO 9001 certification; BIS/type test certificates; Testing: Advance sample testing at AHSP labs or govt/NABL labs; supplier bears external testing costs if required.

• Certification & Compliance: MDR 2017, medical device license, type tests; earlier approvals under DCGI/NDAP.

• Delivery & Handling: Cold chain as per Drug Controller General of India; two-year shelf life with min. remaining shelf life at supply.

• Inspection & Sampling: Post-receipt inspection by Medical Stores head; pre-dispatch inspection optional; sample tests conducted at AHSP labs or govt labs.

Terms, Conditions & Eligibility

• EMD: Not explicitly stated; ensure compliance with bid document requirements and DGCI/NABL norms; uploading mandatory certificates is required.
• Experience/Qualification: ISO 9001 certification required; OEM eligibility through certificates; mandatory BIS licenses and type-test/approval certificates.
• Delivery & Warranty: Shelf life two years or more; stock replacement if near expiry; recalls handled at supplier cost; cold chain maintenance mandatory.
• Documents: GST certificate, PAN, experience certificates, financial statements, EMD documents, technical compliance certificates, OEM authorizations; compliance with Drug Controller General of India norms.
• Penalties: Recall and replacement obligations; price and supply commitments aligned with regulatory requirements.
• Payment: Not specified; ensure alignment with standard government payment terms and delivery conditions.